[1]JournalofMedicinalChemistry,2016,vol.59,p.8082-8093
[2]Patent:US2018/215720,2018,A1.Locationinpatent:Paragraph0057;0059;0073
83942-10-3
5600-21-5
5734-62-3
14394-61-7
83183-56-6 | 2-Chloro-7-(trifluoromethyl)quinoline | AA00G9ZI | MFCD11557207
848133-17-5 | (E)-N-(4-((3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide | AA00GAFK | MFCD26792555
759456-76-3 | 1-(Ethylsulfonyl)piperidin-4-amine hydrochloride | AA00GBLM | MFCD06805737
75655-45-7 | 3-(3-Methyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)propanoic acid | AA00GG34 | MFCD03669039
821-55-6 | 2-Nonanone | AA00GIWP | MFCD00009553
75333-07-2 | (4-BiphenylylMethyl)hydrazine Hydrochloride | AA00GMBJ | MFCD01722362
81022-06-2 | ETHYL 7-ETHOXYIMIDAZO[2,1-B][1,3]BENZOTHIAZOLE-2-CARBOXYLATE | AA00GP7V | MFCD03617496
9036-06-0 | EC 3.4.24.4 | AA00GR8V | MFCD02253017
92346-48-0 | 2-(2-bromophenyl)-1,3-oxazole | AA00GRK5 | MFCD08234434
941289-27-6 | (S)-(1-Boc-Piperidino)acetic acid | AA00GRTK | MFCD03094722